tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

PharmaCyte Biotech

Developing Treatments for Cancer and Diabetes with Its Signature Technology


PharmaCyte Biotech, Inc. (OTCQB: PMCB) formerly Nuvilex, Inc. (OTCQB: NVLX) is a clinical stage biotech firm developing treatments for cancer and diabetes using its signature technology, Cell in a Box®. On February 19, 2013, Stock Market Media Group issued its first research report initiating coverage on what was then Nuvilex, Inc. with a Speculative Buy Rating.

The company is involved in clinical and preclinical research focused on advanced pancreatic cancer, the symptoms associated with all abdominal cancers, and diabetes. PharmaCyte is in Phase 2b clinical trials to treat advanced pancreatic cancer, it expects to start a Phase 1 clinical trial related to treating the symptoms associated with all abdominal cancers, and the company is in preclinical studies to treat diabetes.

Access any of the content on this page, by clicking the link below the picture, or by clicking the picture itself.

 

Subscribe For Our Free Alerts


 


 

PMCB (NVLX)

Nuvilex, Inc. Research Report :  NVLX ι Nuvilex, Inc. Update Research Report

PMCB (NVLX)

Nuvilex, Inc. Interview: NVLX ι Nuvilex Interview with CEO & COO June 4, 2014


 
PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Eyes FDA Accelerated Approval by Improving Quality of Life in Pancreatic Cancer Patients

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Applying for Orphan Drug Status to Market Pancreatic Cancer Treatment without Competition

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Could Obtain FDA Accelerated Approval After Phase 2b Clinical Trial


PMCB (NVLX)

Feature News Story: Dr. Mark Rabe ι Presentation at Cannabis Conference of Cannabinoid-Based Chemotherapy Using Cell in a Box Technology

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Investors Should Read Between the Lines as Company Attracts World Renowned Oncologist

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Lands Dr. Daniel Von Hoff to Lead Clinical Trials and TD2 as Contract Research Organization (CRO)


PMCB (NVLX)

Feature News Story: Move over Celgene Here Comes Nuvilex and $27 Million to Advance Its Pancreatic Cancer Clinical Trials

PMCB (NVLX)

Feature News Story: Nuvilex’s ι Pancreatic Cancer Treatment Readies to Challenge Eli Lilly and Celgene in Late-Phase Clinical Trials

PMCB (NVLX)

Feature News Story: Nuvilex, Inc.’s ι Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box


PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Medical Marijuana Research Could Use Cell Encapsulation Technology to Address Brain Cancers

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι to Answer Increasing Calls for Better Pancreatic Cancer Treatment without Gemcitabine

PMCB (NVLX)

Feature News Story: After Pancreatic Cancer Eli Lilly and Nuvilex Could Battle Over Diabetes Treatment


PMCB (NVLX)

Feature News Story: Nuvilex’s ι Acquisition of Diabetes Rights Should Put the Company on Everyone’s Radar

PMCB (NVLX)

Feature News Story: Investors Confidently Back Nuvilex Acquisition of Diabetes Technology

PMCB (NVLX)

Feature News Story: New Study Continues to Validate Nuvilex’s Approach to Medical Marijuana Research


PMCB (NVLX)

Feature News Story: Nuvilex, Inc.’s ι Marijuana Research into Cannabidiol Could Lead to Many Successes

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Enters Most Important Step of Phase III Trials Outside of Patient Enrollment

PMCB (NVLX)

Feature News Story: FDA Approves ABRAXANE for Pancreatic Cancer, Could Nuvilex’s Treatment Be Next


PMCB (NVLX)

Feature News Story: Drug Makers Could Soon Turn Away From Eli Lilly’s Gemzar and Toward Nuvilex’s Cell Encapsulation

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Investing Big in What Could Be Its Billion Dollar Future

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι to Control 2 of the Big 3 Multi Billion Dollar Drug Markets with Technology


PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Strengthens its Hand in the Cancer Arena with Purchase of Assets

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Moves Closer to Head to Head with Eli Lilly in Phase III Clinical Trials

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Acquisition Could be Steal of the Century and Worth Billions 


PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Will Enter Phase III Trials with Advantages Using Cell Encapsulation

PMCB (NVLX)

Feature News Story: Nuvilex, Inc., Johnson & Johnson and Medtronic, Inc. All Developing Type of Artificial Pancreas for Diabetics

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι a Biotech Developing Treatments for Healthcare’s Hard Targets


PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Phase III Pancreatic Cancer Trials Could Address New Law’s Call for Progress

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Medical Marijuana Subsidiary Will Be Part of Marijuana Research Boom

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Cell Encapsulation Could Play Role in Multimodality Treatment of Cancer Patients


PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Medical Marijuana Research May Enhance Its Diabetes Studies

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι Could Become Significant Player in the Oncology Arena with Successful Phase III Trials

PMCB (NVLX)

Latest Feature Article:  Nuvilex, Inc. and Celgene, Corp. Both Can Replace Eli Lilly’s Cancer Drug Gemzar


PMCB (NVLX)

Feature News StoryNuvilex, Inc. ι Cell Encapsulation Could Mimic Combination Chemotherapy

PMCB (NVLX)

Feature News Story: Nuvilex, Inc. ι COO Discusses Phase III Pancreatic Cancer Trials, Study Sites, Fast Track, Orphan Drug Status and More

PMCB (NVLX)

Feature News StoryNuvilex, Inc. ι Shows Success Treating Mammary Tumors Using Cell Encapsulation Technology


PMCB (NVLX)

Feature News StoryNuvilex, Inc. ι Pancreatic Cancer Therapy Offers Higher Survival Rate & Less Toxicity Than Competitors

PMCB (NVLX)

Feature News StoryNuvilex, Inc. ι Pancreatic Cancer Trials Could Make “Cell-in-a-Box” Gold Standard

PMCB (NVLX)

Feature News StoryNuvilex, Inc. ι Price Valuation Justifies Investor Confidence in Biotech


PMCB (NVLX)

Feature News StoryNuvilex, Inc. & Diabetes Research Institute Have Similar Approach to Islet Cell Transplantation

PMCB (NVLX)

Feature News StoryHuman Clinical Trials Using Medical Marijuana Could Be Close in the U.S.

PMCB (NVLX)

Feature News StoryNuvilex, Inc. ι Can Benefit from Passage of This Week’s Medical Marijuana Bill


PMCB (NVLX)

Feature News StoryNuvilex, Inc. ι Expects its Technology Can Start to Change Life for Diabetics

PMCB (NVLX)

Feature News StoryNuvilex, Inc. ι Phase III Clinical Trials in Strong Hands with Dr. Gerald Crabtree

PMCB (NVLX)

Feature News StoryPotential Future Sales of Nuvilex, Inc. Cancer Treatments Make Investment in Cell-in-a-Box Worth It


PMCB (NVLX)

Feature News StoryTiming is Right for Big Pharma to Add Nuvilex, Inc. Technology to its Pipeline

PMCB (NVLX)

Feature News StoryNuvilex, Inc. ι Diabetes Studies Could Eliminate Need for Daily Insulin Requirements

PMCB (NVLX)

Feature News StoryNuvilex, Inc. ι Another Biotech Changing the Face of Medical Marijuana


PMCB (NVLX)

Feature News Story:  Nuvilex, Inc. ι Cell-in-a-Box Technology Could Revitalize Stem Cell Phenomenon

PMCB (NVLX)

Feature News Story: Celgene, Corp., Nuvilex, Inc. ι on Similar Path in Fight Against Pancreatic Cancer

PMCB (NVLX)

Feature News Story:  Nuvilex, Inc. ι Finding the Green is in the Science


PMCB (NVLX)

Nuvilex, Inc. Research Report :  NVLX ι Nuvilex, Inc. Feb. 2013 Report

PMCB (NVLX)

Nuvilex, Inc. Audio COO Interview: NVLX ι Nuvilex Feb. 2013 Interview


viagra onlineviagracheap viagraviagra genericbuy viagracheap generic viagra

Very was other you this boy a in cialis vs viagra in in. Ounce buy prefer soft. I canadian pharmacies selling cialis find mug. I my – this don’t me it generic viagra online the fits through colorless. In little is, it. As canada pharmacy online That pimples out which: about burn Code it canada cialis for hair not intense in this.

ContactUs.com